[HTML][HTML] 18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O …
J Ottoy, J Verhaeghe, E Niemantsverdriet… - Alzheimer's & …, 2019 - Elsevier
Introduction Dual-biomarker positron emission tomography (PET), providing complementary
information on cerebral blood flow and amyloid-β deposition, is of clinical interest for …
information on cerebral blood flow and amyloid-β deposition, is of clinical interest for …
[PDF][PDF] 18 F-FDG PET, the early phases and the delivery rate of 18 F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15 OH2o …
S Ceyssens, C Van Broeckhoven… - Alzheimer's & …, 2019 - researchgate.net
Introduction: Dual-biomarker positron emission tomography (PET), providing complementary
information on cerebral blood flow and amyloid-b deposition, is of clinical interest for …
information on cerebral blood flow and amyloid-b deposition, is of clinical interest for …
18F驠DG PET, the early phases and the delivery rate of 18F驛V45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O驢2O PET
J Ottoy, J Verhaeghe, E Niemantsverdriet… - Alzheimer's & …, 2019 - Wiley Online Library
Introduction Dual骲iomarker positron emission tomography (PET), providing complementary
information on cerebral blood flow and amyloid螃 deposition, is of clinical interest for …
information on cerebral blood flow and amyloid螃 deposition, is of clinical interest for …
F-18-FDG PET, the early phases and the delivery rate of F-18-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against O-15-H2O PET …
J Ottoy, J Verhaeghe, E Niemantsverdriet… - Alzheimer's & …, 2019 - researchportal.vub.be
INTRODUCTION: Dual-biomarker positron emission tomography (PET), providing
complementary information on cerebral blood flow and amyloid-β deposition, is of clinical …
complementary information on cerebral blood flow and amyloid-β deposition, is of clinical …
18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET
J Ottoy, J Verhaeghe… - … & dementia: the …, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction Dual-biomarker positron emission tomography (PET), providing complementary
information on cerebral blood flow and amyloid-β deposition, is of clinical interest for …
information on cerebral blood flow and amyloid-β deposition, is of clinical interest for …
F-FDG PET, the early phases and the delivery rate of F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: validation against PET
J Ottoy, J Verhaeghe… - … , Ill.]-Orlando, Fla …, 2019 - repository.uantwerpen.be
Introduction Dual-biomarker positron emission tomography (PET), providing complementary
information on cerebral blood flow and amyloid-β deposition, is of clinical interest for …
information on cerebral blood flow and amyloid-β deposition, is of clinical interest for …
18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15OH2O PET.
J Ottoy, J Verhaeghe, E Niemantsverdriet… - … & Dementia: the …, 2019 - europepmc.org
Methods This study included ten controls, 19 amnestic mild cognitive impairment, and 10 AD
dementia subjects. Within-subject regional correlations between modalities, between-group …
dementia subjects. Within-subject regional correlations between modalities, between-group …
[PDF][PDF] 18 F-FDG PET, the early phases and the delivery rate of 18 F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15 OH2o …
S Ceyssens, C Van Broeckhoven… - Alzheimer's & …, 2019 - scholar.archive.org
Introduction: Dual-biomarker positron emission tomography (PET), providing complementary
information on cerebral blood flow and amyloid-b deposition, is of clinical interest for …
information on cerebral blood flow and amyloid-b deposition, is of clinical interest for …